Medikamentenvergleiche
Insulin Aspart Human vs. Troglitazone
Compare Insulin Aspart (fast-acting injectable insulin) and Troglitazone (oral TZD withdrawn for liver risks). Insulin Aspart remains a standard treatment for diabetes.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
Patients with type 2 diabetes who are considering oral medications versus injectable options may compare Insulin Aspart to the discontinued Troglitazone.
Fazit
Insulin Aspart is a viable and commonly prescribed treatment for diabetes, whereas Troglitazone has been removed from the market due to safety concerns.
Alle Medikamentenvergleiche